Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer
暂无分享,去创建一个
M. Wallace | H. Wolfsen | L. Hemminger | K. DeVault | H. C. Wolfsen | L. L. Hemminger | M. Wallace | K. R. DeVault
[1] J. Yu,et al. Simultaneous Screening for Barrett's and Colorectal Cancer , 2004 .
[2] H. Wolfsen,et al. Barrett's Esophagus (BE) Is Common in Older Patients Undergoing Screening Colonoscopy Regardless of Gastroesophageal Reflux (GER) Symptoms , 2004 .
[3] O. Cummings,et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. , 2003, Gastroenterology.
[4] H. Wolfsen,et al. Photodynamic therapy for esophageal diseases: a clinical update. , 2003, Endoscopy.
[5] D. Rex. Is virtual colonoscopy ready for widespread application? , 2003, Gastroenterology.
[6] Masoud Panjehpour,et al. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. , 2003, Gastrointestinal endoscopy.
[7] Kenneth K Wang,et al. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] G. Ginsberg. Endoluminal therapy for Barrett's with high-grade dysplasia and early esophageal adenocarcinoma. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[9] H. Barr,et al. Photodynamic Therapy for Esophageal Cancer: A Useful and Realistic Option , 2003, Technology in cancer research & treatment.
[10] M. Raimondo,et al. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. , 2002, Mayo Clinic proceedings.
[11] G. Triadafilopoulos,et al. Prevalence of Barrett's esophagus in asymptomatic individuals. , 2002, Gastroenterology.
[12] T. Smyrk,et al. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia , 2002, American Journal of Gastroenterology.
[13] S. Spechler,et al. Clinical practice. Barrett's Esophagus. , 2002, The New England journal of medicine.
[14] Noel S Weiss,et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. , 2002, Gastroenterology.
[15] B. Overholt,et al. A multicenter, partially blinded, randomised study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in Barrett's esophagus (BE): Results of 6-month follow-up , 2001 .
[16] B. Reid,et al. Effect of Segment Length on Risk for Neoplastic Progression in Patients with Barrett Esophagus , 2000, Annals of Internal Medicine.
[17] A. Lindgren,et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.
[18] J. Fraumeni,et al. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.
[19] W. Hop,et al. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. , 1995, Gut.
[20] W S Payne,et al. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. , 1985, The New England journal of medicine.
[21] R. Sampliner. Long-term endoscopic surveillance of Barrett's esophagus , 2003, American Journal of Gastroenterology.
[22] R. Sampliner,et al. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus , 2002, American Journal of Gastroenterology.
[23] B. Overholt,et al. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. , 1999, Gastrointestinal endoscopy.
[24] Dawn Provenzale,et al. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk , 1999, American Journal of Gastroenterology.